Kaye Mark 4
4 · CONMED Corp · Filed Jun 4, 2025
Insider Transaction Report
Form 4
CONMED CorpCNMD
Kaye Mark
Director
Transactions
- Award
Options To Purchase Common Stock
2025-06-02+8,061→ 8,061 totalExercise: $55.38From: 2026-06-02Exp: 2035-06-02→ Common Stock (8,061 underlying) - Award
RSUs (Restricted Stock Units)
2025-06-02+668→ 668 totalExercise: $0.00From: 2026-06-02Exp: 2035-06-02→ Common Stock (668 underlying)
Footnotes (2)
- [F1]The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.